Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania. (December 2016)
- Record Type:
- Journal Article
- Title:
- Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania. (December 2016)
- Main Title:
- Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
- Authors:
- Kavishe, Reginald
Kaaya, Robert
Nag, Sidsel
Krogsgaard, Camilla
Notland, Jakob
Kavishe, Adellaida
Ishengoma, Deus
Roper, Cally
Alifrangis, Michael - Abstract:
- Abstract Background Sulfadoxine–pyrimethamine (SP) is recommended for prophylactic treatment of malaria in pregnancy while artemisinin combination therapy is the recommended first-line anti-malarial treatment. Selection of SP resistance is ongoing since SP is readily available in health facilities and in private drug shops in sub-Saharan Africa. This study reports on the prevalence and distribution ofPfdhps mutations A540E and A581G in Tanzania. When found together, these mutations confer high-level SP resistance (sometimes referred to as 'super-resistance'), which is associated with loss in protective efficacy of SP-IPTp. Methods DNA samples were extracted from malaria-positive blood samples on filter paper, used malaria rapid diagnostic test strips and whole blood collected from eight sites in seven administrative regions of Tanzania. PCR–RFLP and SSOP-ELISA techniques were used to genotype the A540E and A581GPfdhps . Data were analysed using SPSS version 18 while Chi square and/or Fischer Exact tests were used to compare prevalence between regions. Results A high inter-regional variation ofPfdhps -540E was observed (χ2 = 76.8, p < 0.001). High inter-regional variation of 581G was observed (FE = 85.3, p < 0.001). Both Tanga and Kagera were found to have the highest levels of SP resistance. A high prevalence ofPfdhps -581G was observed in Tanga (56.6 %) in northeastern Tanzania and in Kagera (20.4 %) in northwestern Tanzania and the 540–581 EG haplotype was found at 54.5Abstract Background Sulfadoxine–pyrimethamine (SP) is recommended for prophylactic treatment of malaria in pregnancy while artemisinin combination therapy is the recommended first-line anti-malarial treatment. Selection of SP resistance is ongoing since SP is readily available in health facilities and in private drug shops in sub-Saharan Africa. This study reports on the prevalence and distribution ofPfdhps mutations A540E and A581G in Tanzania. When found together, these mutations confer high-level SP resistance (sometimes referred to as 'super-resistance'), which is associated with loss in protective efficacy of SP-IPTp. Methods DNA samples were extracted from malaria-positive blood samples on filter paper, used malaria rapid diagnostic test strips and whole blood collected from eight sites in seven administrative regions of Tanzania. PCR–RFLP and SSOP-ELISA techniques were used to genotype the A540E and A581GPfdhps . Data were analysed using SPSS version 18 while Chi square and/or Fischer Exact tests were used to compare prevalence between regions. Results A high inter-regional variation ofPfdhps -540E was observed (χ2 = 76.8, p < 0.001). High inter-regional variation of 581G was observed (FE = 85.3, p < 0.001). Both Tanga and Kagera were found to have the highest levels of SP resistance. A high prevalence ofPfdhps -581G was observed in Tanga (56.6 %) in northeastern Tanzania and in Kagera (20.4 %) in northwestern Tanzania and the 540–581 EG haplotype was found at 54.5 and 19.4 %, respectively.Pfdhps -581G was not detected in Pwani and Lindi regions located south of Tanga region. Conclusions Selection of SP super-resistantPfdhps A581G is highest in northern Tanzania. Variation in distribution of SP resistance is observed across the country: northeastern Tanga region and northwestern Kagera region have highest prevalence of SP super-resistance markers, while in Pwani and Lindi in the southeast the prevalence of super-resistance was zero. More studies should be conducted to understand the factors underlying the remarkable heterogeneity in SP resistance in the country. … (more)
- Is Part Of:
- Malaria journal. Volume 15:Number 1(2016)
- Journal:
- Malaria journal
- Issue:
- Volume 15:Number 1(2016)
- Issue Display:
- Volume 15, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 15
- Issue:
- 1
- Issue Sort Value:
- 2016-0015-0001-0000
- Page Start:
- 1
- Page End:
- 8
- Publication Date:
- 2016-12
- Subjects:
- Plasmodium falciparum -- Sulfadoxine-pyrimethamine -- SP-resistance -- SP-super resistance -- Anti-malarial drugs -- Tanzania -- Drug resistance -- Malaria -- Mutations -- Parasites -- Polymorphisms
Malaria -- Periodicals
616.9362 - Journal URLs:
- http://pubmedcentral.gov/tocrender.fcgi?journal=98 ↗
http://www.malariajournal.com/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s12936-016-1387-2 ↗
- Languages:
- English
- ISSNs:
- 1475-2875
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10065.xml